NCT03487822

Brief Summary

This study examines the effects of PATH-Pain on emotion regulation to improve self-management of pain and pain-related disability in older adults with chronic pain, negative emotions, and cognitive impairment. Half the participants will receive the intervention, and half the participants will receive usual care with education. Intervention subjects are hypothesized to have significantly less pain-related disability versus usual care subjects after 24 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 8, 2017

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 4, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2019

Completed
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

March 19, 2018

Last Update Submit

December 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Current Pain Intensity on an 11 point scale

    Pain intensity is an 11 item scale with a range of 0-11 with a higher score indicating higher pain.

    Baseline, 10 weeks

  • Change in Pain-related disability (RMDQ)

    Pain-related disability as measured by the Roland-Morris Disability Questionnaire (RMDQ). This measure has a range of 0-24, with a higher score indicating higher disability.

    Baseline, 10 weeks

Secondary Outcomes (3)

  • Change in Emotion Regulation Mediation (ERQ)

    Baseline, 10 and 24 weeks

  • Client Satisfaction Questionnaire (CSQ)

    24 weeks

  • Change in Montgomery-Asberg Depression Rating Scale (MADRS)

    Baseline, 10 and 24 weeks

Study Arms (3)

Path Pain

EXPERIMENTAL

Path Pain participants will be receiving 8 weekly therapy session by license clinicians trained in the Path Pain intervention. Participants will also receive 4, 15-minute phone booster sessions, on a monthly basis after their final therapy session. Participants will also be invited to monthly group educational sessions. Both intervention and usual care participants will be receiving a pain educational booklet.

Behavioral: Path Pain

Usual Care with Education

NO INTERVENTION

Usual Care with Education (UCE) will receive a pain educational booklet. Following completion of 24 weeks in the study, participants will also be invited to attend the monthly group educational sessions.

Provider Feedback

NO INTERVENTION

Providers of patients in the study will take part in a short interview on their impressions of the intervention.

Interventions

Path PainBEHAVIORAL

The intervention examines the effects of PATH-Pain on emotion regulation to improve self-management of pain and pain-related disability in older adults with chronic pain, negative emotions, and cognitive impairment. This intervention consists of 8 weekly therapy sessions by a licensed clinician trained in Path Pain, 4 monthly boosters upon completion of therapy, and optional monthly group educational sessions.

Path Pain

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient Participants:
  • and older
  • chronic pain (pain on most days in past 2 months)
  • negative emotions
  • MoCA score 16 or higher
  • Provider Participants:
  • providers 18 or over that took care of patient participant

You may not qualify if:

  • MoCA score \<16
  • cancer related pain
  • can not provide capacity to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center on Aging (formerly Wright Center on Aging)

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Cary Reid, MD, PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR
  • Dimitris Kiosses, PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The co-investigators performing assessments will be blind to the participant's arm.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2018

First Posted

April 4, 2018

Study Start

August 8, 2017

Primary Completion

July 26, 2019

Study Completion

July 26, 2019

Last Updated

December 18, 2024

Record last verified: 2024-12

Locations